Quest Diagnostics Inc.’s DGX robust Advanced Diagnostics offering is poised to drive its growth in the upcoming quarters. Strength in the company’s core business is highly encouraging. Additionally, a ...
Quest Diagnostics Inc.’s DGX investments in Advanced Diagnostics are paying off, aiming to deliver and scale innovative services that improve patient care and drive growth. The company focuses on ...
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.1% year on year to $2.81 billion. The company’s ...
Quest Diagnostics DGX is set to release its second-quarter 2025 results on July 22, before the market opens. The renowned diagnostics provider posted adjusted earnings per share (EPS) of $2.21 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results